Regeneron Pharmaceuticals Inc. (REGN): Price and Financial Metrics

REGN POWR Grades

• Quality is the dimension where REGN ranks best; there it ranks ahead of 90% of US stocks.
• The strongest trend for REGN is in Sentiment, which has been heading down over the past 179 days.
• REGN's current lowest rank is in the Momentum metric (where it is better than 8.18% of US stocks).

REGN Stock Summary

• Regeneron Pharmaceuticals Inc's market capitalization of $75,807,090,727 is ahead of 96.48% of US-listed equities.
• Over the past twelve months, REGN has reported earnings growth of 142.63%, putting it ahead of 85.9% of US stocks in our set.
• As for revenue growth, note that REGN's revenue has grown 89.14% over the past 12 months; that beats the revenue growth of 90.83% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Regeneron Pharmaceuticals Inc are SNPS, LRCX, CDNS, MU, and NXPI.
• REGN's SEC filings can be seen here. And to visit Regeneron Pharmaceuticals Inc's official web site, go to www.regeneron.com.

REGN Valuation Summary

• In comparison to the median Healthcare stock, REGN's price/sales ratio is 48.9% lower, now standing at 5.8.
• REGN's price/sales ratio has moved down 24.1 over the prior 243 months.
• Over the past 243 months, REGN's EV/EBIT ratio has gone up 38.2.

Below are key valuation metrics over time for REGN.

REGN Growth Metrics

Its 4 year price growth rate is now at 52.06%.
• The 3 year cash and equivalents growth rate now stands at 182.76%.
• The 5 year net income to common stockholders growth rate now stands at 214.05%.

REGN's revenue has moved up $9,160,585,000 over the prior 34 months.

The table below shows REGN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	16,071.7	7,081.3	8,075.3
2021-09-30	13,542.9	5,939.8	6,995.5
2021-06-30	12,384.1	2,271.9	6,205.4
2021-03-31	9,197.6	2,588.6	4,003.8
2020-12-31	8,497.1	2,618.1	3,513.2
2020-09-30	8,243.7	2,174.5	3,156

REGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• REGN has a Quality Grade of B, ranking ahead of 86.94% of graded US stocks.
• REGN's asset turnover comes in at 0.683 -- ranking 43rd of 681 Pharmaceutical Products stocks.
• JAZZ, AGLE, and VERU are the stocks whose asset turnover ratios are most correlated with REGN.

The table below shows REGN's key quality metrics over time.